Home Markets Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial

Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial

Dec 08, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/kamada-stock-tumbles-after-discontinuing-phase-3-inhaled-aat-trial-93CH-4395809

You May Also Like

Huawei launches new foldable smartphone; Xiaomi and Apple set to follow

Goldman Sachs Flags Top European Telecom Stocks With Amplified Upside Potential

Evercore ISI Names Top Pick, Lifts Target to $575 on AI Growth

DAX tests 200-SMA after H&S breakdown: Live levels

Indonesia stocks lower at close of trade; IDX Composite Index down 0.16%

Ferrexpo surges 36% after $100 mln raise supports Ukraine production restart